C26H24N6O3
468.5 g/mol
Pharmaceutical IntermediateWarning
Ethyl 1-((2'-(1H-tetrazol-5-yl)-(1,1'-biphenyl)-4-yl)methyl)-2-ethoxy-1H-benzo(d)imidazole-7-carboxylate
CAS139481-58-6EC642-256-1
Category
Pharmaceutical Intermediate
Compound Class
Heterocycle
Primary Use
Pharmaceutical Intermediate
This compound is a benzimidazole derivative featuring a tetrazole-bearing biphenyl substituent and an ethyl ester group. It is primarily utilized as an intermediate in the synthesis of pharmaceutical agents, particularly those targeting the angiotensin II receptor.
pharmaceutical intermediateresearch compound for angiotensin receptor studies
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 139481-58-6
Related Compounds
StrongStructure SimilarSimilarity 0.88
Methyl candesartan
CAS139481-69-9
pharmaceutical raw material
SimilarStructure SimilarSimilarity 0.84
Candesartan
CAS139481-59-7
pharmaceutical raw material
ReferenceSame Category
Trityl candesartan
CAS139481-72-4
pharmaceutical intermediate
ReferenceSame Category
16α-hydroxyprednisolone
CAS13951-70-7
pharmaceutical intermediate
ReferenceSame Category
2-(7-Methoxy-1-naphthyl)ethylamine hydrochloride
CAS139525-77-2
pharmaceutical intermediate
ReferenceSame Category
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-4-methyl-L-leucine
CAS139551-74-9
pharmaceutical intermediate
Safety Reference
Warning
H302Harmful if swallowed
H373May cause damage to organs through prolonged or repeated exposure
Identifiers
IUPAC Name
ethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
InChIKey
BCPWNYREAURMOP-UHFFFAOYSA-N
SMILES
CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)OCC
Synonyms (19)
- Candesartan Cilexetil EP Impurity A
- Candesartan Ethyl Ester
- Ethyl candesartan